ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,5,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1,8,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
1,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1,10,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,12,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
